In addition to the influence of NAMPT on lipid metabolism, we also found that FK866 markedly reduced Akt phosphorylation, indicating that NAMPT also improve insulin resistance in NAFLD through promoting insulin signaling in hepatocytes. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.